Yvonne Gao is specialized in Life Science & Healthcare, Corporate / Merger & Acquisition, Outbound Investment, Private Equity & Investment Funds, Capital Market. Yvonne Gao has rich experience in undertaking projects in cross-border technology transfer/licensing, investment & financing, compliance, product registration and anti-counterfeiting, equity incentive, general legal counsel service, etc. in the Life Science & Health field.
Clients served by Yvonne Gao include but are not limited to the following: CARsgen Therapeutics (Shanghai) Co., Ltd., Curon Biopharmaceutical Limited, Analytical BioSciences Limited, Shanghai Fudan-zhangjiang Bio-Pharmaceutical Co., Ltd. and its all affiliates, Sumitomo Pharmaceuticals (Suzhou) Co., Ltd., Zhejiang Jingxin Pharmaceutical Co., Ltd. and its affiliates, Zhejiang Yuanjin Chemical Co., Ltd., Zhejiang Decans Medical Instrument Co., Ltd., Mission Medical Technologies（Ningbo）Co., Ltd. and its affiliates, BioNova Pharmaceutical Co., Ltd., Shenzhen HwaGen Pharmaceutical Co., Ltd., VSPN, Peking University Yangtze Delta Institute of Optoelectronics, Shoushan wealth Holding Co., Ltd., Trendlines, American ADGERO Fund, Baifu (Changzhou) Health Care Investment Center.
Yvonne Gao joined Global Law Office in 2022. Prior to joining Global Law Office, Yvonne Gao worked with Shanghai AllBright Law Office in the areas of investment and financing, cross-border technology transfer, compliance, anti-counterfeiting and other legal businesses in the pharmaceutical industry (2019-2021) and served as the Legal Counsel in Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (2012-2019).
Admitted in the PRC, New York State, and California.
2008 University of Missouri, LL.M.
2006 Peking University, JM.
2000 China Youth University of Political Studies, LL.B.
In 2021, Yvonne Gao received two awards from the Pharmaceutical and Healthcare Committee of Shanghai AllBright Law Office for Intellectual Property and General Legal Counsel Service.
Founding member of Real Estate Law Research Center of Peking University.
Member of the Management Committee of the special fund for spinal deformity of China Health Promotion Foundation.
Understanding the Medical Innovation Board – Case Analysis of Pharmaceutical and Healthcare Enterprises Listed on the Scientific and Technology Innovation Board, published by Peking University Press, 2020.
Research on the Credit Supplement System of Housing Mortgage Loans in the United States, Japan and China, Frontier of Real Estate Law [2007：2]
On the Solution of Sino US Trade Friction from the Toy Recall Case, won the 2009 Excellent Essay Award of the Ministry of Commerce of China.
